AscellaHealth Announces Key Executive Promotions, Supporting Strategic Growth in the Life Sciences Business Unit

BERWYN, Pa., April 15, 2025 (GLOBE NEWSWIRE) -- AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today announces the promotion of Donovan Quill to chief strategy officer, Life Sciences, and Bob Gilkin, RPh, MBA, to chief commercial and growth officer. In their new positions, Donovan and Bob serve dual appointments, continuing in their leadership roles at AscellaHealth while contributing to the growth of Actum Pharma as an affiliate organization that helps companies fund, develop, manage and market novel, life-changing therapies.

To read more, click here